HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Giardini Selected Research

Monoclonal Antibodies

8/2000Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Giardini Research Topics

Disease

3Breast Neoplasms (Breast Cancer)
01/2015 - 04/2000
2Neoplasms (Cancer)
08/2000 - 04/2000
1Exanthema (Rash)
01/2015
1Chromosome Aberrations (Chromosome Abnormalities)
09/2001
1Hodgkin Disease (Hodgkin's Disease)
09/2001
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2001
1Medulloblastoma
01/2001
1Lymphoma (Lymphomas)
08/2000
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2000
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2000

Drug/Important Bio-Agent (IBA)

2Letrozole (Femara)FDA LinkGeneric
01/2015 - 04/2013
1Pharmaceutical PreparationsIBA
01/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2015
1Sorafenib (BAY 43-9006)FDA Link
01/2015
1Progesterone Receptors (Progesterone Receptor)IBA
04/2013
1Anaplastic Lymphoma KinaseIBA
09/2001
1Pyridinolcarbamate (P23)IBA
09/2001
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2000
1Monoclonal AntibodiesIBA
08/2000
1Rituximab (Mabthera)FDA Link
08/2000
1Collagen Type XVIII (Type XVIII Collagen)IBA
04/2000
1Antineoplastic Agents (Antineoplastics)IBA
04/2000
1CarcinogensIBA
04/2000
19,10-Dimethyl-1,2-benzanthraceneIBA
04/2000
1EndostatinsIBA
04/2000
1Immunoglobulins (Immunoglobulin)IBA
02/2000

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2001 - 08/2000
1Therapeutics
04/2000